Omegalight® is a patented active ingredient developed by Solabia Group, designed to address skin hyperpigmentation and promote a more even skin tone. It combines piperonyl alcohol and linoleic acid in an ester form, synthesized through an enzymatic process. This formulation aims to optimize the bioavailability and effectiveness of the active components while ensuring safety and stability in cosmetic formulations.

Mechanism of Action:

Omegalight® operates by regulating melanogenesis—the process of melanin production—within skin cells. It specifically targets the PPAR (Peroxisome Proliferator-Activated Receptor) pathways α, δ, and γ, which are involved in the expression of genes related to pigmentation. By modulating these pathways, Omegalight® effectively inhibits key enzymes such as tyrosinase and TRP-1, which are critical in melanin synthesis. This dual action helps in reducing the formation of dark spots and uneven skin tone, even under stress conditions. Solabia

Benefits:

• Reduces Hyperpigmentation: Targets and diminishes age spots, dark spots, and melasma.

• Enhances Skin Radiance: Promotes a brighter and more luminous complexion.

• Anti-Inflammatory Properties: Helps soothe the skin and reduce redness.

• Improves Skin Texture: Contributes to a smoother and more even skin surface.

Applications:

Omegalight® is suitable for incorporation into various cosmetic formulations, including:

• Serums and Creams: Targeted treatments for pigmentation issues.

• Masks: Intensive treatments for skin brightening.

• Lotions: Daily use products for maintaining an even skin tone.

Its versatility and efficacy make it a valuable ingredient for developing products aimed at consumers seeking solutions for hyperpigmentation and uneven skin tone.